The shares benefited from a clutch of analyst price target hikes. A clutch of post-earnings price target increases by analysts helped raise Medtronic's (MDT 3.59%) stock at a healthy rate on Wednesday. The sturdy medical device specialist's shares rose by almost 4% on the day as a consequence, a rate that looked especially good next to the S&P 500's (^GSPC -0.24%) 0.2% drop. The market, which collectively loves a crushing beat on analyst estimates, basically shrugged at this. Many investors traded out of Me ...